1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Recalls

Jaundice Meters Recalled Because Displays Too Easy To Misinterpret

 
• By Elizabeth Orr

Draeger has recalled two devices used to detect jaundice in newborns after users misinterpret display.

After finding that users are misinterpreting some of the results from its newborn jaundice meters, Draeger Medical Inc. is updating labeling, offering training and upgrading software in an action that has been designated as a highest-risk class I recall by FDA.

The recall targets two models of jaundice meters linked to misintepretations that could delay treatment.Clinicians use the Draeger Jaundice Meter...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Recalls

More from Policy & Regulation

Planning To Take Part in MDUFA? FDA Wants To Hear From You

 
• By Brian Bossetta

The US FDA needs to know who wants a seat at the MDUFA negotiations table before discussions can begin. The agency is asking stakeholders to let it know if they plan to participate in the periodic consultation meetings before July 28.

Global Medtech Guidance Tracker: June 2025

 
• By Vibha Sharma

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 50 documents have been posted on the tracker since its last update.

Finland Cracks Down On Software That Needs Regulating As A Medical Devices

 
• By Amanda Maxwell

Finland has initiated a project to improve the effectiveness of the monitoring of software intended for medical use and to ensure that software placed on its market meets the requirements set for it.